Literature DB >> 9709947

Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.

N N'Diaye1, J Tremblay, P Hamet, W W De Herder, A Lacroix.   

Abstract

Abnormal responsiveness of adrenocortical cells to gastric inhibitory polypeptide (GIP) in food-dependent Cushing's syndrome suggested that adrenal expression of ectopic, overexpressed, or mutated GIP receptor (GIPR) underlies this syndrome. The expression of GIPR was studied by RT-PCR in human adrenal tissues from two patients with GIP-dependent Cushing's syndrome (adenoma, bilateral hyperplasia), five fetal or adult controls, one patient with Cushing's disease, and four patients with non-food-dependent cortisol-secreting adenomas or bilateral hyperplasias and compared to that in normal pancreas. Hybridization of the RT-PCR-amplified ribonucleic acids with the human GIPR complementary DNA showed an overexpression of GIPR in the adrenals of the two GIP-dependent Cushing's syndrome patients compared to that in normal adrenal tissues (2-3 orders of magnitude) or pancreas (10-fold); no signal could be seen in adrenal adenomas or macronodular hyperplasia from cases of non-food-dependent Cushing's syndrome. No mutation of the GIPR was identified by sequencing the full-length receptor in GIP-dependent adrenal tissue. New alternative spliced isoforms of the GIPR were found, but are identical in GIP-dependent and normal adrenal tissues. Incubation of adrenal cells with GIP stimulates cortisol secretion in GIP-dependent, but not in normal fetal, adult, or non-food-dependent Cushing's syndrome, adrenals. We conclude that the GIPR overexpression and its coupling to steroidogenesis underlie GIP-dependent Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709947     DOI: 10.1210/jcem.83.8.5038

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.

Authors:  Nobuhiro Miyamura; Tetsuya Taguchi; Yusuke Murata; Kayo Taketa; Shinsuke Iwashita; Kazuya Matsumoto; Takeshi Nishikawa; Tetsushi Toyonaga; Michiharu Sakakida; Eiichi Araki
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 2.  Aberrant expression of hormone receptors in adrenal Cushing's syndrome.

Authors:  Stavroula Christopoulos; Isabelle Bourdeau; André Lacroix
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 3.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

4.  Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.

Authors:  Anne-Lise Lecoq; Constantine A Stratakis; Say Viengchareun; Ronan Chaligné; Lucie Tosca; Vianney Deméocq; Mirella Hage; Annabel Berthon; Fabio R Faucz; Patrick Hanna; Hadrien-Gaël Boyer; Nicolas Servant; Sylvie Salenave; Gérard Tachdjian; Clovis Adam; Vanessa Benhamo; Eric Clauser; Anne Guiochon-Mantel; Jacques Young; Marc Lombès; Isabelle Bourdeau; Dominique Maiter; Antoine Tabarin; Jérôme Bertherat; Hervé Lefebvre; Wouter de Herder; Estelle Louiset; André Lacroix; Philippe Chanson; Jérôme Bouligand; Peter Kamenický
Journal:  JCI Insight       Date:  2017-09-21

5.  A case of severe hypertension caused by ACTH-independent macronodular adrenal hyperplasia.

Authors:  R Nocente; Marinis L De; A Mancini; A Bianchi; R Bellantone; L Lauriola; M Costanzo; Crea C De; G Gasbarrini; Silveri N Gentiloni
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

6.  Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus.

Authors:  Marcia Helena Soares Costa; Sorahia Domenice; Rodrigo Almeida Toledo; Delmar Muniz Lourenço; Delmar Muniz Junior Lourenço; Ana Claudia Latronico; Emilia Modolo Pinto; Sergio Pereira Almeida Toledo; Berenice Bilharinho Mendonca; Maria Candida Barisson Villares Fragoso
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Physiologic and pharmacologic modulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta-cells by peroxisome proliferator-activated receptor (PPAR)-gamma signaling: possible mechanism for the GIP resistance in type 2 diabetes.

Authors:  Dhananjay Gupta; Mina Peshavaria; Navjot Monga; Thomas L Jetton; Jack L Leahy
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

8.  Case report: Adrenal LH/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome.

Authors:  Michael Herman Chui; Michael Herman Chui; Nese Colak Ozbey; Shereen Ezzat; Yersu Kapran; Yesim Erbil; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

9.  G protein-coupled receptor expression in the adult and fetal adrenal glands.

Authors:  Yewei Xing; Yasuhiro Nakamura; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2008-11-05       Impact factor: 4.102

10.  Marked cortisol production by intracrine ACTH in GIP-treated cultured adrenal cells in which the GIP receptor was exogenously introduced.

Authors:  Hiroko Fujii; Mimi Tamamori-Adachi; Kousuke Uchida; Takao Susa; Takashi Nakakura; Haruo Hagiwara; Masayoshi Iizuka; Hiroko Okinaga; Yuji Tanaka; Tomoki Okazaki
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.